Marston NA, Ruff CT, Sabatine MS. Response by Marston et al to Letter Regarding Article, "The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism". Circulation 2020;142:e264.
PMID: 33104403